![While conventional cosmetic bottles produced by blow and blow processes feature weight-volume ratios of 1.0/3.0, the new 200 ml Nova bottle, with a brimful volume of 215 ml and weight of 140 g, reportedly boasts a weight-volume ratio 0.65 without losing the durability or safety of the Dorado model.](https://img.gcimagazine.com/files/base/allured/all/image/2023/12/NOVA_range_1.656e0bca50c5b.png?auto=format%2Ccompress&q=70&w=700)
SGD Pharma's new pharma-grade Nova lightweight glass bottle packaging features a reduced carbon footprint compared to full-weight counterparts.
The new bottle design adapts the company's narrow neck press and blow capabilities, previously displayed in its Clareo glass vial designs.
As applied to the Nova design, the process allows for bottle weight reduction and optimized glass distribution for enhanced mechanical resistance to withstand transport and distribution stresses.
Meanwhile, the reduced packaging weight minimizes associated greenhouse gas emissions, per SGD Pharma. A new 200 ml Nova bottle's lower raw material consumption reportedly reduces CO2 emissions by approximately 20% compared with the standard Dorado bottles.
Furthermore, while conventional cosmetic bottles produced by blow and blow processes feature weight-volume ratios of 1.0/3.0, the new 200 ml Nova bottle, with a brimful volume of 215 ml and weight of 140 g, reportedly boasts a weight-volume ratio 0.65 without losing the durability or safety of the Dorado model.
Chunyan Zheng, deputy general manager of industrial operation at SGD Pharma’s Zhanjiang plant, said, “Nova is the latest innovation from our Zhanjiang plant in China, representing the ‘star’ performance needed by beauty brands of both aesthetics and functionality. SGD Pharma has a proven record of quickly addressing changing customer needs and Nova is the manifestation of our ambition for improved ecological performance and reduced manufacturing emissions, making it the optimal packaging solution for 21st century cosmetic brands."
Frédéric Barbier, general manager of SGD Pharma BU APAC, noted, “SGD Pharma’s global goal is to reduce its carbon footprint 35% by 2030, and 65% by 2040 (compared with 2020 baseline), scope 1 & 2. SGD Pharma recently announced its participation in the science-based targets initiative (SBTi) and is currently working on the 1.5°C scenario decarbonization pathway validation including scope 3 emissions. Nova is one of many actions we take to advance our ambitious decarbonization strategy. Our experienced team can support beauty brands in the development of their own lightweight bottle while maintaining the functional integrity and design potential of packaging.”